Europe, CIS & Africa Spatial Transcriptomics Market To Reach $256.1 Million By 2030

Europe, CIS & Africa Spatial Transcriptomics Market Growth & Trends

The Europe, CIS & Africa spatial transcriptomics market size is anticipated to reach USD 256.1 million by 2030, growing at a CAGR of 15.57% from 2024 to 2030, according to a new report by Grand View Research, Inc. The emerging potential of spatial omics analysis for cancer research, the advent of the fourth generation of sequencing (in situ sequencing), and increasing funding & collaborative initiatives in spatial biology research are likely to contribute to market growth. Moreover, the growing prevalence of chronic diseases necessitates efficient biomarker discovery and early & accurate diagnosis for effective disease management and treatment.

The spatial biology field has observed rapid development in the past few years. Commercial advancements in spatial multiomics methods, with increased capacity, multiplexity, and improved resolution, are some of the factors driving market growth. New instruments with higher multiplexing capabilities and resolution are enabling researchers to obtain more detailed insights from spatial analyses. End-to-end scalable and reproducible workflows make it easier for researchers to conduct spatial analysis efficiently. In addition, ongoing developments in the field are expected to further accelerate the integration of spatial biology into various stages of the drug discovery pipeline.

Furthermore, spatial omics analysis enables the identification of spatially resolved molecular signatures that can serve as potential biomarkers for cancer diagnosis and prognosis. By analyzing the spatial distribution of specific molecules within the tumor microenvironment, researchers can uncover novel biomarkers that may not be detectable using traditional omics approaches. In addition, by understanding the spatial organization of different cell populations and their interactions, clinicians can tailor treatment regimens to target specific subpopulations more effectively within a tumor. For instance, according to an article published in The Lancet in October 2022, scientists studied tissue architecture in Esophageal Squamous Cell Carcinoma (ESCC) by integrating microarray-based spatial transcriptomics and single-cell RNA sequencing.

The COVID-19 pandemic significantly impacted the market, with disruptions in supply chains and manufacturing processes leading to shortages and delays in manufacturing timelines. However, post-pandemic advancements in bioinformatics and computational biology have simplified the interpretation of complex datasets generated by ST, expanding its applications across various industries such as pharmaceuticals, biotechnology, and research institutions. Furthermore, the heightened awareness and interest in medical research due to the pandemic have further boosted the growth of the market.

However, one significant restraint of the market is the high cost associated with the technologies and instruments required for spatially resolved molecular profiling. The expense of acquiring and maintaining these advanced instruments can pose a barrier to entry for researchers and healthcare providers, especially those operating in resource-constrained environments. This financial challenge may limit access to innovative spatial transcriptomic technologies, hindering research progress and potentially impeding advancements in personalized medicine & disease understanding.

 Request a free sample copy or view report summary: Europe, CIS & Africa Spatial Transcriptomics Market Report

Europe, CIS & Africa Spatial Transcriptomics Market Report Highlights

• Consumables dominated the product segment in 2023 owing to the high product penetration, increasing use of reagents & kits, wide product availability, and frequent purchase of consumables to run instruments.

• In 2023, sequencing-based methods dominated the technology segment and held the largest revenue share in 2023. Furthermore, the microscopy-based RNA imaging techniques segment is expected to grow at a significant CAGR over the forecast period.

• On the basis of workflow, the sample preparation segment held the largest revenue share of 55.49% in 2023 as it is crucial for obtaining high-quality sequencing products for performing genomics & transcriptomics studies.

• The FFPE segment dominated the sample type segment in terms of revenue in 2023. New techniques are devised for gene expression profiling in FFPE that further drive segment growth. However, the fresh frozen segment is anticipated to grow at the highest CAGR of 17.14% from 2024 to 2030.

• Translational research dominated the end use market with the largest share in 2023. By mapping gene expression patterns within tissues, spatial transcriptomics helps understand molecular mechanisms underlying disease pathogenesis. Researchers can identify key genes and pathways associated with specific diseases, leading to the discovery of potential therapeutic targets.

• Europe region dominated the market with a share of 94.57% in 2023, owing to factors such as increasing investments in R&D activities, established biotechnology R&D sector, and presence of key players.

Europe, CIS & Africa Spatial Transcriptomics Market Segmentation

Grand View Research has segmented the Europe, CIS & Africa spatial transcriptomics market based on product, technology, workflow, sample type, end-use, and region:

Europe, CIS & Africa Spatial Transcriptomics Product Outlook (Revenue, USD Million, 2018 - 2030)

• Instruments

• By Mode

• Automated

• Semi-automated

• Manual

• By Type

• Sequencing Platforms

• IHC

• Microscopy

• Flow Cytometry

• Mass Spectrometry

• Others

• Consumables

• Software

• Bioinformatics Tools

• Imaging Tools

• Storage And Management Databases

Europe, CIS & Africa Spatial Transcriptomics Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Sequencing-based Methods

• Laser Capture Microdissection (LCM)

• Transcriptome In-Vivo Analysis (TIVA)

• In Situ Sequencing

• Microtomy Sequencing

• IHC

• Microscopy-based RNA Imaging Techniques

• Single Molecule RNA Fluorescence In-Situ Hybridization (smFISH)

• Padlock Probes/ Rolling Circle Amplification

• Branched DNA Probes

Europe, CIS & Africa Spatial Transcriptomics Workflow Outlook (Revenue, USD Million, 2018 - 2030)

• Sample Preparation

• Instrumental Analysis

• Data Analysis

Europe, CIS & Africa Spatial Transcriptomics Sample Type Outlook (Revenue, USD Million, 2018 - 2030)

• FFPE

• Fresh Frozen

Europe, CIS & Africa Spatial Transcriptomics End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Translational Research

• Academic Customers

• Diagnostic Customers

• Pharmaceutical Manufacturer

Europe, CIS & Africa Spatial Transcriptomics Regional Outlook (Revenue, USD Million, 2018 - 2030)

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

  • Netherlands

  • Belgium

  • Finland

  • Switzerland

  • Poland

• The Commonwealth of Independent States (CIS)

• Africa

  • South Africa

  • Nigeria

  • Morocco

List of Key Players in the Europe, CIS & Africa Spatial Transcriptomics Market

• Illumina, Inc.

• Bruker

• 10X Genomics

• EdenRoc Sciences (Cantata Bio, LLC)

• Shimadzu Corporation

• Waters Corporation

• Bio-Techne

• Vizgen Inc.

• Spatial Genomics

• Akoya Biosciences, Inc